InMode Ltd.
HealthcareNASDAQ:INMD · NASDAQ Global Select
-$0.04 today
Vol 0.43M · Avg 0.87M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$374.6M of revenue converted into $87.2M of net income for the selected period. Gross margin is 77.7% and net margin is 22.9%, showing how much revenue survives after costs and taxes. EPS is $1.36, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $370.5M -6.2% | $394.8M -19.8% | $492.0M +8.3% | $454.3M +27.0% | $357.6M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $79.5M +2.3% | $77.8M -3.7% | $80.7M +9.8% | $73.5M +37.1% | $53.6M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $291.0M -8.2% | $317.1M -22.9% | $411.3M +8.0% | $380.8M +25.3% | $304.0M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 78.5% -1.8pp | 80.3% -3.3pp | 83.6% -0.2pp | 83.8% -1.2pp | 85.0% | 9.8% | 28.9% | 38.3% |
| Research & Development | $13.3M +1.4% | $13.1M -2.0% | $13.4M +7.9% | $12.4M +30.4% | $9.5M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $192.3M +0.5% | $191.4M -5.4% | $202.3M +18.6% | $170.5M +33.5% | $127.8M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $205.6M +0.5% | $204.5M -5.2% | $215.7M +17.9% | $182.9M +34.0% | $136.5M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $695.0K -4.5% | $728.0K +16.9% | $623.0K -8.4% | $680.0K +31.5% | $517.0K | $374.2M | $1.2B | $631.8M |
| EBITDA | $111.0M -23.0% | $144.2M -33.8% | $217.9M +7.8% | $202.1M +20.0% | $168.5M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 30.0% -6.6pp | 36.5% -7.8pp | 44.3% -0.2pp | 44.5% -2.6pp | 47.1% | 5.6% | 46.3% | 42.0% |
| Operating Income | $85.4M -24.1% | $112.5M -42.5% | $195.7M -1.1% | $197.9M +18.1% | $167.5M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 23.0% -5.5pp | 28.5% -11.3pp | 39.8% -3.8pp | 43.6% -3.3pp | 46.8% | 16.6% | 24.1% | 22.0% |
| Interest Income | $24.9M -19.4% | $30.9M +43.2% | $21.6M +498.2% | $3.6M +588.0% | $525.0K | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | $24.9M -19.4% | $30.9M +43.2% | $21.6M +498.2% | $3.6M +588.0% | $525.0K | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $110.3M -23.1% | $143.5M -34.0% | $217.3M +7.8% | $201.5M +19.9% | $168.0M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 29.8% -6.6pp | 36.3% -7.8pp | 44.2% -0.2pp | 44.3% -2.6pp | 47.0% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $16.5M +143.6% | -$37.8M -295.4% | $19.3M -51.6% | $39.9M +1264.3% | $2.9M | $1.3B | -$1.6B | $745.2M |
| Net Income | $93.8M -48.2% | $181.3M -8.4% | $197.9M +22.5% | $161.5M -2.1% | $165.0M | $4.9B | $4.8B | $4.7B |
| Net Margin | 25.3% -20.6pp | 45.9% +5.7pp | 40.2% +4.7pp | 35.6% -10.6pp | 46.1% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $1 -36.7% | $2 -3.4% | $2 +20.9% | $2 -3.4% | $2 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $1 -36.4% | $2 -2.2% | $2 +21.7% | $2 -1.6% | $2 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $64.6M -18.5% | $79.3M -5.1% | $83.5M +1.3% | $82.5M +1.3% | $81.4M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $65.4M -18.8% | $80.6M -6.2% | $86.0M +0.6% | $85.4M -0.7% | $86.0M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
AnaptysBio, Inc.
NASDAQ:ANAB
$2.42B
AxoGen, Inc.
NASDAQ:AXGN
$2.29B
Integra LifeSciences Holdings Corporation
NASDAQ:IART
$1.38B
AdaptHealth Corp.
NASDAQ:AHCO
$1.38B
IRadimed Corporation
NASDAQ:IRMD
$1.20B
Tandem Diabetes Care, Inc.
NASDAQ:TNDM
$1.14B
OPKO Health, Inc.
NASDAQ:OPK
$1.07B
Xencor, Inc.
NASDAQ:XNCR
$914.17M
Oculis Holding AG
NASDAQ:OCS
$634.01M
Claritev Corporation
NYSE:CTEV
$526.61M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does INMD generate?
InMode Ltd. (INMD) reported $370.50M of revenue in fiscal 2025.
Is INMD profitable?
InMode Ltd. (INMD) reported $93.83M of net income, with a net margin of 25.3%.
Explore More
Continue the stock analysis
Jump to another research area for this company.